Skip to Content
Merck
CN
  • Nkx2-5 suppresses the proliferation of atrial myocytes and conduction system.

Nkx2-5 suppresses the proliferation of atrial myocytes and conduction system.

Circulation research (2014-02-25)
Yasuhiro Nakashima, Diana A Yanez, Marlin Touma, Haruko Nakano, Artur Jaroszewicz, Maria C Jordan, Matteo Pellegrini, Kenneth P Roos, Atsushi Nakano
ABSTRACT

Tight control of cardiomyocyte proliferation is essential for the formation of four-chambered heart. Although human mutation of NKX2-5 is linked to septal defects and atrioventricular conduction abnormalities, early lethality and hemodynamic alteration in the mutant models have caused controversy as to whether Nkx2-5 regulates cardiomyocyte proliferation. In this study, we circumvented these limitations by atrial-restricted deletion of Nkx2-5. Atrial-specific Nkx2-5 mutants died shortly after birth with hyperplastic working myocytes and conduction system including two nodes and internodal tracts. Multicolor reporter analysis revealed that Nkx2-5-null cardiomyocytes displayed clonal proliferative activity throughout the atria, indicating the suppressive role of Nkx2-5 in cardiomyocyte proliferation after chamber ballooning stages. Transcriptome analysis revealed that aberrant activation of Notch signaling underlies hyperproliferation of mutant cardiomyocytes, and forced activation of Notch signaling recapitulates hyperproliferation of working myocytes but not the conduction system. Collectively, these data suggest that Nkx2-5 regulates the proliferation of atrial working and conduction myocardium in coordination with Notch pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Connexin 40 Antibody, Chemicon®, from rabbit